The FDA is ordering new label warnings for popular GLP-1 drugs over a rare optic nerve condition that can permanently damage sight For millions of Americans, GLP-1 drugs have become a lifeline for managing diabetes and a fast track to serious weight loss. The medications come up in barbershops, group chats and social media feeds […]
The postFDA orders weight-loss drugmakers to add blindness warningsappeared first onRolling Out.



